| Literature DB >> 24094433 |
Chia-Chung Lee1, Deh-Ming Chang, Kuo-Feng Huang, Chun-Liang Chen, Tsung-Chih Chen, Yang Lo, Jih-Hwa Guh, Hsu-Shan Huang.
Abstract
A series of 2,7-diamidofluorenones were designed, synthesized, and screened by SRB assay. Some synthesized compounds exhibited antitumor activities in submicromolar range. Ten compounds (3a, 3b, 3c, 3g, 3j, 3l, 4a, 4h, 4i, and 4j) were also selected by NCI screening system and 3c (GI50=1.66 μM) appeared to be the most active agent of this series. Furthermore, 3c attenuated topoisomerase I-mediated DNA relaxation at low micromolar concentrations. These results indicated that fluorenones have potential to be further developed into anticancer drugs. CrownEntities:
Keywords: Fluorenones; NCI 60-cell panel assay; Tilorone; Topoisomerase I
Mesh:
Substances:
Year: 2013 PMID: 24094433 DOI: 10.1016/j.bmc.2013.09.006
Source DB: PubMed Journal: Bioorg Med Chem ISSN: 0968-0896 Impact factor: 3.641